Buyer for a GMP API manufacturing site in Europe

Company to buy

Industry: Pharmaceuticals
Subindustry: API Manufacturing
Revenue: 3-30 million EUR
Location: Europe
#CFIE PHB293

Overview of buyer for a GMP API manufacturing site in Europe

The buyer, a prominent high-tech enterprise in China’s pharmaceutical sector, has been operational for over 15 years and is listed on the Shanghai Stock Exchange. With a workforce exceeding 1,000, the company boasts a robust R&D team of over 300 highly skilled professionals. Their focus is on the research, development, manufacturing, and marketing of a wide array of pharmaceutical products. Currently, the company is actively seeking to acquire a GMP-certified active pharmaceutical ingredient (API) manufacturing facility in Europe, with a strong commitment to ensuring that the prospective site complies with the highest standards of Good Manufacturing Practice (GMP)

Profile (strategy) of the buyer

The company’s strategy centers on continuous innovation and market expansion, focusing on specialized pharmaceutical formulations and key intermediates. For the past three years, over 10% of operating revenue has been allocated to R&D, ensuring a competitive edge through technological advancements. The product portfolio addresses hepatology, pulmonology, cardiology, and oncology, serving a diverse global clientele.

The acquisition strategy aims to enhance production capabilities and expand presence in the European market. The company prioritizes innovation and compliance with international health standards to facilitate the seamless integration of new facilities into existing operations.

Subscribe as an interested seller
Contact us to get details about this buyer for a GMP API manufacturing site in Europe

Activities of suitable targets

The buyer is interested in facilities that are capable of manufacturing API and that have the necessary infrastructure for research and development. Additional interests include:

API manufacturing facilities with GMP certification
R&D labs for pharmaceutical development
Formulation manufacturing capabilities
Office spaces for administrative functions
Potential for expansion through additional land acquisition

Highlights of buyer for a GMP API manufacturing site in Europe

A strong company with steady economic growth
Maintains a diverse product portfolio for market adaptability
Is committed to technological innovation for competitive advantage
Operates internationally, exporting to Europe, the U.S., Japan, and South Korea
Aims to strengthen its presence in the European pharmaceutical sector
Is seeking a GMP-certified API manufacturing facility in Europe for improved production and regulatory compliance

More information on this buyer for a GMP API manufacturing site in Europe

Please get in touch if you are interested in learning more about this buyer for a GMP API manufacturing site in Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CMO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.